Lupus patient registry for better care
Part of Immune system & allergy, Skin clinical trials.
This trial collects health data from people recently diagnosed with lupus to improve treatment and care. It is a registry study, not a drug-testing trial, and aims to understand how patients fare over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have been diagnosed with lupus (or your doctor strongly suspects it) within the past 6 months.
- You have active disease with a SLEDAI score above 6 (indicates moderate to severe activity).
- You meet the 2019 ACR/EULAR lupus criteria.
- You can provide informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study keeps a long-term record of people with lupus (systemic lupus erythematosus) and collects samples so researchers can study the disease better. You may be able to join if you meet lupus diagnosis criteria, are not pregnant, and can follow the study visits and consent process.
This study creates a registry for people with lupus and their families. It helps researchers learn more about lupus and improve care. You or your child can join if you have a lupus diagnosis.
This trial tests a new treatment for people with active lupus who haven't responded well to steroids and at least two other immune-suppressing drugs, including a biologic. It aims to find a better option for controlling lupus symptoms.
This is a registry study for people living with systemic lupus erythematosus (lupus). By joining, you help researchers collect information about lupus to better understand the disease and improve care.
This registry tracks the safety and effectiveness of lupus treatments over time. If you have SLE and are starting a new treatment or were recently diagnosed, joining helps doctors learn which medicines work best.
This is a registry that follows adults with newly diagnosed lupus (within 5 years) to better understand the disease and care needs over time. It may help researchers and doctors learn what to expect early in lupus and improve future treatment planning.
Hear when a new Systemic Lupus Erythematosus (SLE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.